Clinical Trials Logo

Clinical Trial Summary

Extraction of laboratory data from blood tests prior to surgical and chemotherapy and other histological, clinical and instrumental data related to the patient's history from the digitized medical Digitized medical records and analysis of the same. The medical records of 1000 patients from January 1, 2000, until December 31, 2020


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05100368
Study type Observational
Source Istituto Ortopedico Rizzoli
Contact
Status Completed
Phase
Start date April 2, 2021
Completion date July 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT05440786 - CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma Phase 2
Completed NCT01661400 - Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors Phase 1
Completed NCT03275818 - Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma Phase 2
Not yet recruiting NCT04890093 - Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors Phase 1/Phase 2
Recruiting NCT05046314 - A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma Phase 2
Recruiting NCT06387485 - A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning N/A
Active, not recruiting NCT02415816 - Diffusion Weighted Magnetic Resonance in Imaging Younger Patients With Newly Diagnosed Bone or Soft Tissue Sarcomas N/A
Active, not recruiting NCT03778996 - SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma Phase 2
Terminated NCT02581384 - Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors Phase 1/Phase 2
Enrolling by invitation NCT05772312 - Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage Surgery
Withdrawn NCT02557854 - HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors Phase 1
Terminated NCT03495921 - A Trial For Participants With Ewing's Sarcoma Treated With Vigil in Combination With Irinotecan and Temozolomide Phase 3
Terminated NCT02657005 - TK216 in Patients With Relapsed or Refractory Ewing Sarcoma Phase 1/Phase 2